FDA Recall Database: Class II Recall: BD GasPak EZ Campy Pouch System. Catalog Number:… by Becton Dickinson & Co.

Key facts

What this classification means

FDA classifies a recall as Class II when using the recalled product, or being exposed to it, may cause temporary or medically reversible adverse health consequences, or when the probability of serious adverse health consequences is remote. In this case, the recalling firm is Becton Dickinson & Co. and the affected product is described in FDA's record as: BD GasPak EZ Campy Pouch System. Catalog Number: 260685. for microbiologic use. FDA's stated reason for the recall is: BD identified an issue affecting certain lots of BD GasPak EZ CO2 and BD GasPak EZ Campy Gas Generating Pouch Systems, where gas generating sachets may produce carbon dioxide levels below specification.. The recall is tracked under FDA recall number Z-1983-2026 and carries a status of Ongoing as of the most recent FDA enforcement report. This classification reflects FDA's assessment of the product defect described above, not a prediction about any specific patient outcome. FDA maintains a public enforcement report database so that consumers, physicians, and purchasers can look up the exact product identifiers involved before deciding what to do. Recall status can change while FDA and the recalling firm continue corrective actions, so checking the firm's own notice for the most current guidance is recommended.

What consumers should do

Because this recall carries FDA's middle severity classification, anyone who has this product should stop using it and follow the recalling firm's instructions, even though serious harm is considered unlikely for this classification. Specifically, check whether the product in your possession matches the description on file with FDA -- BD GasPak EZ Campy Pouch System. Catalog Number: 260685. for microbiologic use -- and the recall number Z-1983-2026. If it matches, stop using or distributing it and contact Becton Dickinson & Co. or the point of purchase for return or replacement instructions. Retailers and distributors holding affected inventory should quarantine it and follow the firm's written recall notice. FDA maintains a public enforcement report database so that consumers, physicians, and purchasers can look up the exact product identifiers involved before deciding what to do.

Becton Dickinson & Co.’s FDA history

Argus HQ has recorded 2 total FDA actions tied to Becton Dickinson & Co.: 0 warning letters, 2 recalls, 0 approval records, and 0 Form 483 inspection citations.

Frequently asked questions

Where can I verify this recall directly with FDA?

The verbatim FDA record is the source of truth for every recall Argus HQ tracks — always confirm against fda.gov before acting.

What was recalled and why?

Becton Dickinson & Co. recalled BD GasPak EZ Campy Pouch System. Catalog Number: 260685. for microbiologic use. FDA's record states the reason for recall as: BD identified an issue affecting certain lots of BD GasPak EZ CO2 and BD GasPak EZ Campy Gas Generating Pouch Systems, where gas generating sachets may produce carbon dioxide levels below specification.. The recall is logged under FDA recall number Z-1983-2026 with a Class II classification.

How serious is this recall?

FDA classifies a recall as Class II when using the recalled product, or being exposed to it, may cause temporary or medically reversible adverse health consequences, or when the probability of serious adverse health consequences is remote.

What should someone who has this product do?

Because this recall carries FDA's middle severity classification, anyone who has this product should stop using it and follow the recalling firm's instructions, even though serious harm is considered unlikely for this classification. Check the product against FDA's description (BD GasPak EZ Campy Pouch System. Catalog Number: 260685. for microbiologic use) and recall number Z-1983-2026, then follow Becton Dickinson & Co.'s recall instructions.

Related enforcement actions